Somatic Mutations Activating the mTOR Pathway in Dorsal Telencephalic Progenitors Cause a Continuum of Cortical Dysplasias

Cell Rep. 2017 Dec 26;21(13):3754-3766. doi: 10.1016/j.celrep.2017.11.106.

Abstract

Focal cortical dysplasia (FCD) and hemimegalencephaly (HME) are epileptogenic neurodevelopmental malformations caused by mutations in mTOR pathway genes. Deep sequencing of these genes in FCD/HME brain tissue identified an etiology in 27 of 66 cases (41%). Radiographically indistinguishable lesions are caused by somatic activating mutations in AKT3, MTOR, and PIK3CA and germline loss-of-function mutations in DEPDC5, NPRL2, and TSC1/2, including TSC2 mutations in isolated HME demonstrating a "two-hit" model. Mutations in the same gene cause a disease continuum from FCD to HME to bilateral brain overgrowth, reflecting the progenitor cell and developmental time when the mutation occurred. Single-cell sequencing demonstrated mTOR activation in neurons in all lesions. Conditional Pik3ca activation in the mouse cortex showed that mTOR activation in excitatory neurons and glia, but not interneurons, is sufficient for abnormal cortical overgrowth. These data suggest that mTOR activation in dorsal telencephalic progenitors, in some cases specifically the excitatory neuron lineage, causes cortical dysplasia.

Keywords: brain malformations; cortical development; epilepsy; excitatory neurons; focal cortical dysplasia; hemimegalancephaly; mTOR pathway; next-generation sequencing; single-cell sequencing; somatic mutations.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Lineage
  • Class I Phosphatidylinositol 3-Kinases / genetics
  • Hemimegalencephaly / genetics
  • Hemimegalencephaly / pathology
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Malformations of Cortical Development / genetics*
  • Mice
  • Mutation / genetics*
  • Neurons / metabolism
  • Neurons / pathology
  • Signal Transduction*
  • Stem Cells / metabolism*
  • TOR Serine-Threonine Kinases / metabolism*
  • Telencephalon / pathology*

Substances

  • TOR Serine-Threonine Kinases
  • Class I Phosphatidylinositol 3-Kinases
  • PIK3CA protein, human